A new study led by scientists at The Wistar Institute, in collaboration with the University of Pennsylvania Perelman School ...

Findings show potential for new lipid-based delivery formulations as a platform technology for immunizationPhiladelphia, PA, ...

In the past decade, DNA vaccines have emerged as a potential favoured strategy for inducing immunity. Not only are they cost-effective and free of infection risk, but they can elicit both strong ...

Clinical-stage biotechnology company Vaxxas has announced the publication of data supporting the potential use of its high-density microarray patch ...

The Florida surgeon general in January 2024 called for a halt in the use of COVID mRNA vaccines. And in Texas, Attorney ...

2). DNA vaccines contain the nucleotides encoding an antigenic portion of the virus such as the viral core region or envelope region. The DNA is taken up into the host cell, translated ...

causing “integration” of contaminated DNA, State Surgeon General Dr. Joseph Ladapo said in a letter to the FDA in 2024. But vaccine makers say these concerns are misinformation ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

The mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and misinformation — are now a target of legislators in some conservative-led states.

Each vaccine may vary somewhat in how it works, but each would generally follow these steps. DNA vaccines contain genetic material that carries the blueprint for the spike protein. To get the DNA ...

The DNA vaccine, owned by private biotechnology company Technovalia, and delivered by Vaxxas’ HD-MAP, generated a significant antibody response in mice against multiple domains of the spike ...

USA Today has fact checked claims about health risks of COVID-19 vaccines and found that there is no evidence DNA fragments ...